These findings suggest that loss of Mgat5 renders pancreatic tumor cells more susceptible to TNF-α and TRAIL by lowering the threshold for cells to undergo apoptotic and/or necroptotic cell death. The gene discussed is TNF; the disease is pancreatic neoplasm.